Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications
- 18 March 2003
- journal article
- Published by Elsevier
- Vol. 47 (1-2) , 45-52
- https://doi.org/10.1016/0165-1838(94)90064-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi.The Journal of Experimental Medicine, 1992
- Chagas' cardioneuropathy: Effect of ganglioside treatment in chronic dysautonomic patients—A randomized, double-blind, parallel, placebo-controlled studyAmerican Heart Journal, 1991
- Pathogenesis of cardiac neuro-myopathy in Chagas' disease and the role of the autonomic nervous systemJournal of the Autonomic Nervous System, 1990
- Elevated Cerebroside Antibody Levels in Human Visceral and Cutaneous leishmaniasis, Trypanosoma rangeli Infection, and Chronic Chagas' DiseaseThe American Journal of Tropical Medicine and Hygiene, 1990
- Identification of anti‐acetylcholinesterase and anti‐idiotype antibodies in human and experimental Chagas+ disease: pathological implicationsEuropean Journal of Immunology, 1988
- Chagasic IgG modifies the activity of sarcolemmal ATPases through a β adrenergic mechanismLife Sciences, 1987
- L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' diseaseEuropean Journal of Immunology, 1987
- Modification of sarcolemmal enzymes by chagasic IgG and its effect of cardiac contractilityBiochemical Pharmacology, 1986
- Neuropathy associated with experimental Chagas' diseaseAnnals of Neurology, 1985
- Chagasic CardiopathyCirculation, 1974